agilon health, inc. (AGL)
After hours:
| Previous close | 6.90 |
| Open | 6.86 |
| Bid | 6.95 x 2200 |
| Ask | 6.98 x 2900 |
| Day's range | 6.66 - 6.99 |
| 52-week range | 4.41 - 21.52 |
| Volume | |
| Avg. volume | 4,100,812 |
| Market cap | 2.838B |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
agilon health Names Jeff Schwaneke New Chief Financial Officer
AUSTIN, Texas, June 05, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Jeff Schwaneke, an experienced finance, operational and managed care executive and director on agilon’s board, will join the Company as chief financial officer and executive vice president effective July 1, 2024. He will be a member of agilon’s Executive Leadership team reporting to chief executive officer (CEO), Steve Sell. Sc
- Business Wire
agilon health to Participate at 44th Annual William Blair Growth Stock Conference
AUSTIN, Texas, May 29, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 44th Annual William Blair Growth Stock Conference including a presentation on Wednesday, June 5, at 12:20 PM Eastern Time.
- Business Wire
agilon health Reports First Quarter 2024 Results
AUSTIN, Texas, May 07, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the first quarter ended March 31, 2024.
